GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: TXA709 is an orally bioavailable prodrug of TXA707 (PubChem: 90135655), a benzamide antibacterial compound that inhibits the essential and conserved prokaryotic cell division protein FtsZ [3]. TXA709 is under clinical development, as a combination therapy with synergistic drug partners, for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) [1-2].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| N-[2,6-difluoro-3-[[6-(trifluoromethyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]methoxy]benzoyl]-1-methylpiperidine-4-carboxamide |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
TXA-709, active metabolite TXA-707 |
| Other databases | |
| CAS Registry No. | 1609670-80-5 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL3908543 |
| GtoPdb PubChem SID | 491299942 |
| PubChem CID | 75203933 |
| Search Google for chemical match using the InChIKey | LOTYKTRNFDRNAY-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | LOTYKTRNFDRNAY |
| UniChem Compound Search for chemical match using the InChIKey | LOTYKTRNFDRNAY-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | LOTYKTRNFDRNAY-UHFFFAOYSA-N |